Cantor Fitzgerald Comments on Atyr PHARMA FY2026 Earnings
Atyr PHARMA INC (NASDAQ:ATYR – Free Report) – Cantor Fitzgerald issued their FY2026 earnings per share estimates for Atyr PHARMA in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will post earnings per share of ($0.78) for the year. The consensus estimate for Atyr PHARMA’s current full-year […]
